Press Releases : BioMarin BioMarin's Gene Therapy Manufacturing Facility Recognized with Industry Award One of the largest gene therapy facilities received Facility of the Year Award for Project Execution from the International Society for Pharmaceutical Engineering Wed, 21 Mar 2018 05:35:00 -0700 BioMarin to Attend Upcoming Investor Conference - Cowen and Company 38th Annual Health Care Conference on March 13 in Boston Tue, 06 Mar 2018 05:30:00 -0800 Rare Disease Day 2018: BioMarin Launches RARE Scholars Scholarship Program Sculpture Unveiled to Honor Rare Disease Patients Wed, 28 Feb 2018 05:30:00 -0800 BioMarin Announces Fourth Quarter and Full Year 2017 Financial Results - Record Total Revenues of $1.3 Billion for Full Year 2017 Representing an 18% Increase Year over Year Thu, 22 Feb 2018 13:05:00 -0800 BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at WORLDSymposiumâ„¢ 2018 Normalization of biomarker and liver size; stabilization of early cognitive effects suggested in preliminary data Wed, 07 Feb 2018 09:15:00 -0800